Phase II study of interferon-alpha and doxycycline for advanced renal cell carcinoma.
Huie M, Oettel K, Van Ummersen L, Kim KM, Zhang Y, Staab MJ, Horvath D, Marnocha R, Douglas J, Drezen A, Alberti D, Wilding G.
Huie M, et al. Among authors: kim km.
Invest New Drugs. 2006 May;24(3):255-60. doi: 10.1007/s10637-005-3903-z.
Invest New Drugs. 2006.
PMID: 16205854
Clinical Trial.